Pricing Log in Create free account
Saturday 17 October 2026 Export ISRG’s income statement to Excel — free account

Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Intuitive Surgical, Inc. (ISRG) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Jul 23, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 16 added · 6 removed · 60 modified
P2I1A: 3 added · 1 modified
8-K Jul 16, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 28, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Apr 30, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 7.01 Regulation FD disclosure
10-Q Mar 31, 2026
8-K Apr 21, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 1, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 15 added · 17 removed · 88 modified
1A: 12 added · 18 removed · 141 modified
7: 38 added · 48 removed · 100 modified
8-K Jan 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 14, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 16, 2025 5.02 Departure or appointment of directors or officers
10-Q Sep 30, 2025
8-K Oct 21, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.